Experimentation With Screening for Bronchopulmonary Cancer and Primary Cardiovascular Prevention, Early Management of COPD and an Offer Exempted From Smoking Cessation

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2032

Conditions
the Rate of Participation in Screening for PBC
Interventions
OTHER

screening for bronchopulmonary cancer

The screening program includes performing a low-dose chest CT scan (STBD), spirometry, blood sampling (biobank + screening for cardiovascular risk factors) on inclusion, at 1 year and at 2 years. Subsequently, a telephone interview will be scheduled for 3 years to collect medical information, for a total follow-up period of 5 years. At each visit, a structured offer of smoking cessation will be proposed and a collection of the quality of life will be carried out. Each year, a telephone call from participants will be scheduled in order to maximize participation

All Listed Sponsors
lead

Centre Hospitalier Intercommunal Creteil

OTHER

NCT05440123 - Experimentation With Screening for Bronchopulmonary Cancer and Primary Cardiovascular Prevention, Early Management of COPD and an Offer Exempted From Smoking Cessation | Biotech Hunter | Biotech Hunter